Search

Search Constraints

You searched for: Author/Creator Takei, Syuji

Search Results

2. A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan. Issue 6 (8th September 2015)

3. A56: Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab. Issue 11 (March 2014)

4. A56: Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab. Issue Volume 66:Issue(2014)supplement 3 (March 2014)

5. Characteristics and outcome of intractable vasculitis syndrome in children: Nation-wide survey in Japan. Issue 4 (4th July 2018)

6. Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation. Issue 11 (9th July 2020)

7. Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018. Issue 1 (2nd January 2019)

8. Current human T‐cell lymphotropic virus type 1 mother‐to‐child transmission prevention status in Kagoshima. Issue 4 (August 2014)

9. Disease activity score in 28 joints at 3 months after the initiation of biologic agent can be a predictive target for switching to the second biologic agent in patients with polyarticular juvenile idiopathic arthritis. Issue 3 (3rd May 2016)

10. Early prediction for over two years efficacy of the first biologic agent for polyarticular juvenile idiopathic arthritis: A multi-institutional study in Japan. Issue 5 (3rd September 2018)